Moon; Og-Sung

Patent Applications and Registrations

Patent applications and USPTO patent grants for Moon; Og-Sung.The latest application filed is for "novel o-acyloxime derivatives, preparation method thereof, and pharmaceutical composition containing the same for prevention and treatment of cardiovascular disease".

Company Profile

0.7.5

Moon; Og-Sung - Daejeon KR
Moon; Og-Sung - Taejeon-si KR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
O-acyloxime derivatives, preparation method thereof, and pharmaceutical composition containing the same for prevention and treatment of cardiovascular disease Grant 8,399,662 - Jeong , et al. March 19, 2	2013-03-19
Abietane diterpenoid compound, and composition comprising extract of torreya nucifera, or abietane diterpenoid compounds or terpenoid compounds isolated from them for prevention and treatment of cardiovascular disease Grant 7,825,162 - Jeong , et al. November 2, 2	2010-11-02
Abietane diterpenoid compound, and composition comprising extract of Torreya nucifera, or abietane diterpenoid compounds or terpenoid compounds isolated from them for prevention and treatment of cardiovascular disease Grant 7,820,212 - Jeong , et al. October 26, 2	2010-10-26
Novel O-acyloxime Derivatives, Preparation Method Thereof, And Pharmaceutical Composition Containing The Same For Prevention And Treatment Of Cardiovascular Disease App 20100056780 - JEONG; Tae-Sook ; et al.	2010-03-04
O-acyloxime derivatives, preparation method thereof, and pharmaceutical composition containing the same for prevention and treatment of cardiovascular disease Grant 7,642,291 - Jeong , et al. January 5, 2	2010-01-05
Abietane diterpenoid compound, and composition comprising extract of torreya nucifera, or abietane diterpenoid compounds or terpenoid compounds isolated from them for prevention and treatment of cardiovascular disease Grant 7,517,542 - Jeong , et al. April 14, 2	2009-04-14
Novel Abietane Diterpenoid Compound, And Composition Comprising Extract Of Torreya Nucifera, Or Abietane Diterpenoid Compounds Or Terpenoid Compounds Isolated From Them For Prevention And Treatment Of Cardiovascular Disease App 20090062384 - Jeong; Tae-Sook ; et al.	2009-03-05
Novel Abietane Diterpenoid Compound, And Composition Comprising Extract Of Torreya Nucifera, Or Abietane Diterpenoid Compounds Or Terpenoid Compounds Isolated From Them For Prevention And Treatment Of Cardiovascular Disease App 20080299238 - Jeong; Tae-Sook ; et al.	2008-12-04
Novel abietane diterpenoid compound, and composition comprising extract of torreya nucifera, or abietane diterpenoid compounds or terpenoid compounds isolated from them for prevention and treatment of cardiovascular disease App 20070190192 - Jeong; Tae-Sook ; et al.	2007-08-16
Novel O-acyloxime Derivatives, Preparation Method Thereof, And Pharmaceutical Composition Containing The Same For Prevention And Treatment Of Cardiovascular Disease App 20060106017 - JEONG; Tae-Sook ; et al.	2006-05-18
Bioflavonoids as plasma high density lipoprotein level increasing agent Grant 6,133,241 - Bok , et al. October 17, 2	2000-10-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.